Stay updated with breaking news from Selective Endogenous. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The following press release was issued today by the Broad Institute of MIT and Harvard. Researchers from MIT, the McGovern Institute for Brain Research at
Researchers from MIT, the McGovern Institute for Brain Research at MIT, the Howard Hughes Medical Institute, and the Broad Institute of MIT and Harvard have developed a new way to deliver molecular therapies to cells.
Using a family of mammalian proteins adopted from ancient retroviral legacy genes, researchers have developed a novel system for programmable intracellular mRNA delivery.